Clinical trial
Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity
NCT04441996 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity
- Lead sponsor
- Emory University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 17, 2020
- Completion date
- March 18, 2021
- Enrollment
- 20 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.